Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 125 de 366 resultados encontrados
Opções avançadas
Data de publicação: 03/08/2022 - 10:22
A partnership with the World Health Organization that started being drawn in March this year went a step further last Friday (07/29). If four months ago the assistant director general of the WHO’s Division of Intelligence and Surveillance Systems for Emergencies in Health, Chikwe Ihekweazu, brought the proposal that Fiocruz would participate in the Hub for Pandemic and Epidemic Intelligence that the WHO is assembling in Berlin, this time...
Notícias
Data de publicação: 28/07/2022 - 11:49
In 2020 and 2021, COVID-19 killed more than three times as many children aged 6 months to 3 years than the sum of all deaths in this age group over the past decade from diseases that can kill and are preventable by vaccines. The data was collected by the Observatory of Health in Childhood - Observes Childhood (Fiocruz/Unifase) from the Mortality Information System (SIM). For the analysis, researchers Patricia Boccolini and Cristiano Boccolini...
Notícias
Data de publicação: 28/07/2022 - 11:23
The Leonidas & Maria Deane Institute (ILMD/Fiocruz Amazônia), in partnership with the United Nations Children's Fund (UNICEF) and non-governmental organizations Indigenous Medicine Center and Health of the Indigenous Peoples of the Amazon, promoted the Training Workshop of Young Indigenous Communicators, with the theme Indigenous Medicine. The objective was to prepare communicators who will follow in the future the workshops on...
Notícias
Data de publicação: 20/07/2022 - 11:34
With the goal of strengthening integrated influenza surveillance and COVID-19, the Oswaldo Cruz Foundation (Fiocruz), the Pan American Health Organization (PAHO) and the U.S. Centers for Disease Control and Prevention (CDC) promoted training for nine countries in the Caribbean region. The course focused on molecular diagnosis and epidemiology of Influenza and SARS-CoV-2 viruses. Representatives from Antigua and Barbuda, Barbados, Bahamas,...
Notícias
Data de publicação: 15/07/2022 - 17:17
The applications are open for the 1st International Forum on Social Technology and Innovation for People and The Planet, which will occur from July 19th to 21st in Salvador. The event, which will be hybrid, will gather representatives from Fiocruz, the United Nations (UN), the government of Portugal and European Union, among others, to discuss, mainly, social technology and innovation within the 2030 Agenda for Sustainable Development. The event...
Notícias
Data de publicação: 12/07/2022 - 16:18
Two researchers of the Immunology Department of Fiocruz Pernambuco, Haiana Schindler and Lílian Montenegro, are in Mumbai, India, for scientific activities involving technology transfer as defined in the BRICS-Tuberculosis project. Schindler and Montenegro are, respectively, coordinator and vice-coordinator of the project. The invitation came from Indian scientist Vinay Saini, director of the TUMAAS Foundation & Startup and senior...
Notícias
Data de publicação: 06/07/2022 - 14:06
Since the beginning of the pandemic, COVID-19 has been killing two children under 5 years old every day in Brazil. Overall, 599 children this age died of COVID-19 in 2020. In 2021, when the lethality of the disease increased among the entire population, the number of children victims of the virus jumped to 840. A total of 1,439 children below 5 years old died of COVID-19 in the country during the first two years of the pandemic. The Northeast...
Notícias
Data de publicação: 24/06/2022 - 12:53
A research conducted by the Sabin Vaccine Institute and by Fiocruz Mato Grosso do Sul will evaluate the possibility of fractioning booster doses of vaccines for COVID-19. The research shall reveal if smaller doses can offer the same immunological response with fewer adverse reactions. It would allow to multiply the amount of vaccines, especially in poor countries, and guide new immunization strategies. According to Sabin Institute, only 17.4% of...
Notícias
Data de publicação: 10/06/2022 - 16:17
An influent figure in the field of science, technology and innovation, and former Portuguese minister, Manuel Heitor visited Fiocruz last Tuesday, June 7. The professor at the Superior Technical Institute of the University of Lisbon came with two missions: to further expand a collaborative laboratory program that Portuguese institutions already have with the Foundation and to look for new areas for collaboration. By the end of the visit, new...
Notícias
Data de publicação: 08/06/2022 - 15:25
The Seventy-fifth World Health Assembly was held in Geneva, on 22-28 May 2022, with the theme "Health for peace, peace for health". For dozens of years, World Health Assemblies (WHAs) went unnoticed by the general public. However, since the emergence of the COVID-19 pandemic, they have been drawing the attention of politicians, diplomats and the civil society. Health has become an important part of the big policy. Not only because of...
Notícias
Data de publicação: 24/05/2022 - 11:13
Some solutions found by Fiocruz for certain health issues in Brazil, including during the pandemic, could work as a basis for response in other countries. This was one of the conclusions of a group of representatives of Doctors Without Borders (DWB or MSF, in the acronym in portuguese), who visited the Foundation last monday (May 16). They discussed issues such as production and access to vaccines and medicines, effects of COVID-19 on...
Notícias
Data de publicação: 20/05/2022 - 17:15
On a six-day trip to Portugal, the president of the Oswaldo Cruz Foundation, Nísia Trindade Lima, was received by 14 Portuguese authorities, including three ministers, two rectors, an ambassador, and directors and presidents of institutions involving health, education, technology, and innovation, to deepen and structure inter-institutional cooperation between Fiocruz and Portuguese organizations. The trip took place between the last week...
Notícias
Data de publicação: 17/05/2022 - 17:10
Half the people diagnosed with COVID-19 present sequelae that may last for more than a year. This is one of the conclusions of a longitudinal study developed at Fiocruz Minas, which evaluated the effects of the disease over time. The research followed, for 14 months, 646 patients who had had the infection, and verified that 324 of them, that is, 50.2%, had post-infection symptoms, characterizing what the World Health Organization (WHO)...
Notícias
Data de publicação: 13/05/2022 - 16:36
During a visit to Fiocruz last Friday (6 May), the World Health Organization's (WHO) technical lead for COVID-19 response, Maria Van Kerkhove, debated the learnings and challenges necessary to maintain investments that were focused on the pandemic's preparedness for possible new public health emergencies. After getting to know more about the Foundation’s actions and visiting the Laboratory for Measles and Respiratory Viruses of the...
Notícias
Data de publicação: 09/05/2022 - 14:08
Through its Institute of Drug Technology (Farmanguinhos), Fiocruz signed last Tuesday (May 3) an agreement of technological cooperation with American pharmaceutical company MSD (Merck Sharp & Dohme). The goal is to manufacture in Brazil the first oral antiviral drug to treat COVID-19. Last Wednesday (May 4) afternoon, Brazil’s National Agency for Health Surveillance (Anvisa) released the authorization to use the drug in the country on...
Notícias
Data de publicação: 28/04/2022 - 15:05
“There are many nuclear missiles in the world. Why don’t we have enough plants to produce vaccines?” The demand came from Adrian Hill, director of the Jenner Institute, of the University of Oxford. One of the main developers of the Oxford/AstraZeneca COVID-19 vaccine, Hill attended the Symposium on Emerging and Persisting Global Health Threats, organized by Fiocruz and by the National Institute of Allergy and Infectious...
Notícias
Data de publicação: 14/04/2022 - 14:16
Last Monday, April 11, was the first day of the international workshop Innovation by Entrepreneurship, promoted by Fiocruz in a partnership with the Pasteur Institute. The purpose of the event, which will continue on Tuesday, April 12, is to present the results of entrepreneurship initiatives of both institutions and to promote a debate between their researchers. Marco Krieger, Fiocruz vice-president of Production and Innovation in Health,...
Notícias
Data de publicação: 13/04/2022 - 15:05
Delegations from the Danish government and the National Institute of Industrial Property (Inpi) visited Fiocruz last Wednesday (4/6) as part of cooperation activities for innovation in Health between Brazil and the European country. The cooperation relationship is in phase 2, dedicated to the health issue, and, following an invitation from Inpi, Fiocruz has been participating in the project. The Foundation's delegations and representatives...
Notícias
Data de publicação: 12/04/2022 - 17:58
A new study by Fiocruz, published in Lancet Infectious Diseases last Thursday (March 31), shows that even people with previous infection by Sars-CoV-2 have higher protection levels when vaccinated. The highest effectiveness was observed with the four vaccines in use in Brazil (Coronavac, AstraZeneca, Janssen, and Pfizer-BioNTech) in the prevention of COVID-19. The research shows increased protection against infection and, in particular, against...
Notícias
Data de publicação: 12/04/2022 - 17:33
Released this Friday (April 4), the Fiocruz COVID-19 Observatory Report shows maintenance of the falling trend of COVID-19 incidence and mortality indicators. The document highlights that for the first time since May 2020, no Brazilian state has exceeded 0.3 deaths per 100,000 inhabitants. The researchers state that according to these new data it is possible to say that the third epidemic wave in Brazil, with a predominance of Omicron among the...
Notícias
Data de publicação: 08/04/2022 - 15:33
Last Tuesday (March 29), Fiocruz and Drugs for Neglected Diseases initiative (DNDi) signed a Memorandum of Understanding for dengue fever research and treatment. The occasion also sealed a Strategic Research Alliance between the two institutions and the joint submission of a project to the Finep Public Call for Neglected Diseases. In addition to signing the Memorandum of Understanding for dengue fever, the occasion sealed a Strategic...
Notícias
Data de publicação: 30/03/2022 - 10:15
In a meeting promoted on March 28, by the Center for International Relations in Health (Cris/Fiocruz) and the Vice-Presidencies of Research and Biological Collections (VPPCB) and Education, Information and Communication (VPEIC), members of the Consulate General of the United States in Rio de Janeiro continued the partnership process initiated in 2021. The aim is to expand scientific cooperation between Fiocruz and American institutions....
Notícias
Data de publicação: 24/03/2022 - 15:43
At a meeting that took place last Friday (March 19), representatives of Fiocruz and of the Deutsche Forschungsgemeinschaft (DFG), a German non-profit organization that stimulates research, got together to strengthen bilateral cooperation between the institutions and to discuss possible foment partnerships. As a first step in this direction, a workshop was suggested to evaluate the opportunities, identifying possibilities among ongoing projects...
Notícias
Data de publicação: 23/03/2022 - 16:44
Unitaid, the global health agency connected to the WHO, will be financing the implementation of the project for Injectable Pre-Exposure Prophylaxy in Brazil, using long-acting Cabotegravir. With only six injections per year, the method has proven to be more effective than daily oral PrEP in terms of reducing the risk of infection by the virus. The project will be coordinated by the Evandro Chagas National Infectiology Institute (INI/Fiocruz) in...
Notícias

Pages

Back to the topBack